GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31

GENELUX Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.45+0.03 (+1.24%)

Close on Oct 19, 2026

Market cap: $110.15M
P/E (TTM): –
Dividend yield: –

GENELUX Corp balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash & Equivalents	5.33	8.57	9.42	0.40	4.50
Short-Term Investments	–	22	14	–	–
Cash & Short-Term Investments	5.33	31	23	0.40	4.50
Prepaid Expenses & Other	0.54	0.65	1.01	1.50	–
Total Current Assets	15	32	24	1.89	–
Property, Plant & Equipment	2.17	1.32	1.17	0.64	–
Gross Property, Plant & Equipment	6.10	5.00	4.62	3.59	–
Accumulated Depreciation	-3.93	-3.68	-3.45	-2.95	–
Operating Lease Right-of-Use Assets	1.58	1.76	2.43	1.34	–
Other Long-Term Assets	0.14	0.09	0.09	0.09	–
Total Assets	19	35	28	5.53	–
Accounts Payable	4.36	5.57	3.78	6.78	–
Short-Term Debt	–	–	0.90	–	–
Current Debt	–	–	0.90	–	–
Current Portion of Leases	0.43	0.33	0.65	0.27	–
Deferred Revenue (Current)	–	–	–	0.17	–
Total Current Liabilities	6.23	6.90	6.55	32	–
Long-Term Leases	1.26	1.54	1.87	1.16	–
Operating Lease Liabilities	1.69	1.87	2.52	1.43	–
Total Liabilities	7.48	8.44	8.42	41	–
Total Debt	–	–	0.90	–	–
Preferred Stock	–	–	–	0.02	–
Common Stock	0.04	0.04	0.03	0.01	–
Additional Paid-In Capital	295	278	241	154	–
Retained Earnings	-284	-251	-222	-190	–
Treasury Stock	-0.43	-0.43	-0.43	-0.43	–
Comprehensive Income & Other	0.01	0.06	0.01	0.00	–
Shareholders' Equity	12	26	19	-36	-33
Total Equity	12	26	19	-36	-33
Total Liabilities & Equity	19	35	28	5.53	–
Shares Outstanding(shares)	38	35	27	9.13	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -455275.0%
Net margin: -444950.0%
Return on equity, FY2025: -170.0%

Financial strength

Current ratio: 2.39
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 114.8%

Valuation

P/E ratio: –
Price to sales: 13768.82
Price to book: 6.84
Dividend yield: –